Holen Sie sich die Stockscreener-App
0.796
6.78%
-0.0579
Handel nachbörslich:
.80
0.004
+0.50%
Schlusskurs vom Vortag:
$0.8539
Offen:
$0.81
24-Stunden-Volumen:
161.47K
Relative Volume:
1.05
Marktkapitalisierung:
$5.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0572
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
-5.36%
1M Leistung:
+12.11%
6M Leistung:
-26.30%
1J Leistung:
-82.07%
1-Tages-Spanne:
$0.7666
$0.83
1-Wochen-Bereich:
$0.75
$0.91
52-Wochen-Spanne:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.796 | 6.69M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Can Pasithea Therapeutics Corp. Equity Warrant outperform in the next rallyWeekly Investment Summary & Daily Chart Pattern Signals - khodrobank.com
Pasithea Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
Relative strength of Pasithea Therapeutics Corp. in sector analysisJuly 2025 Rallies & Comprehensive Market Scan Reports - Newser
How to track smart money flows in Pasithea Therapeutics Corp.2025 Top Decliners & Daily Profit Focused Screening - Newser
Volume spikes in Pasithea Therapeutics Corp. stock – what they meanJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Will Pasithea Therapeutics Corp. bounce back from current supportJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser
Sector ETF performance correlation with Pasithea Therapeutics Corp. Equity Warrant2025 Market Trends & Community Supported Trade Ideas - Newser
Will Pasithea Therapeutics Corp. stock hit new highs in YEARGap Down & Verified Chart Pattern Signals - khodrobank.com
Real time alert setup for Pasithea Therapeutics Corp. performance2025 Fundamental Recap & Weekly High Momentum Picks - Newser
Will Pasithea Therapeutics Corp. Equity Warrant outperform the market2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Signal strength of Pasithea Therapeutics Corp. stock in tech scannersDollar Strength & Capital Efficiency Focused Ideas - Newser
Sector ETF performance correlation with Pasithea Therapeutics Corp.2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
Is it too late to sell Pasithea Therapeutics Corp. Equity WarrantEarnings Beat & Risk Managed Investment Entry Signals - Newser
Pasithea Therapeutics Corp. stock prediction for this week2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
Can volume confirm reversal in Pasithea Therapeutics Corp. Equity Warrant - Newser
Applying Wyckoff theory to Pasithea Therapeutics Corp. Equity Warrant stockMarket Trend Report & Capital Efficiency Focused Strategies - Newser
What’s next for Pasithea Therapeutics Corp. stock priceAnalyst Downgrade & Safe Capital Growth Plans - Newser
Risk adjusted return profile for Pasithea Therapeutics Corp. analyzedTrade Risk Report & Growth Oriented Trade Recommendations - Newser
Can you recover from losses in Pasithea Therapeutics Corp. Equity Warrant2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
How to escape a deep drawdown in Pasithea Therapeutics Corp.Trade Analysis Report & Risk Managed Trade Strategies - Newser
Is Pasithea Therapeutics Corp. Equity Warrant meeting your algorithmic filter criteriaJuly 2025 WrapUp & Long-Term Safe Return Strategies - Newser
How institutional ownership impacts Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Outlook & AI Optimized Trade Strategies - Newser
sector etf performance correlation with pasithea therapeutics corp. equity warrantWeekly Stock Summary & Safe Entry Zone Identification - Newser
Long term hold vs stop loss in Pasithea Therapeutics Corp.Earnings Overview Report & Consistent Return Strategy Ideas - Newser
Momentum divergence signals in Pasithea Therapeutics Corp. chartWeekly Trend Report & Intraday High Probability Setup Alerts - Newser
How to forecast Pasithea Therapeutics Corp. Equity Warrant trends using time seriesJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Key metrics from Pasithea Therapeutics Corp. Equity Warrant’s quarterly dataPortfolio Value Summary & Growth Focused Stock Pick Reports - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp.2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. Equity Warrant strategiesQuarterly Investment Review & Real-Time Volume Spike Alerts - Newser
Building trade automation scripts for Pasithea Therapeutics Corp.2025 Big Picture & Long-Term Capital Growth Ideas - Newser
What Fibonacci levels say about Pasithea Therapeutics Corp. Equity Warrant reboundJuly 2025 Big Picture & Low Drawdown Investment Ideas - Newser
Pasithea Therapeutics Corp. Equity Warrant Tests 50 Day MA After Sharp DeclineJuly 2025 Patterns & Verified Momentum Stock Ideas - beatles.ru
What’s next for Pasithea Therapeutics Corp. Equity Warrant stock priceQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser
Using fundamentals and technicals on Pasithea Therapeutics Corp. Equity Warrant2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Pasithea Therapeutics Corp. stock volume spike explainedMarket Performance Recap & AI Driven Stock Price Forecasts - Newser
Is Pasithea Therapeutics Corp. affected by consumer sentiment2025 Major Catalysts & High Accuracy Swing Entry Alerts - khodrobank.com
Using RSI to spot recovery in Pasithea Therapeutics Corp. Equity WarrantWeekly Gains Report & Smart Money Movement Tracker - Newser
Will Pasithea Therapeutics Corp. Equity Warrant outperform during market ralliesEarnings Miss & Free Real-Time Market Sentiment Alerts - khodrobank.com
Best data tools to analyze Pasithea Therapeutics Corp. stockQuarterly Market Summary & Daily Price Action Insights - Newser
Published on: 2025-09-02 17:00:25 - khodrobank.com
Sentiment analysis tools applied to Pasithea Therapeutics Corp.July 2025 Breakouts & Daily Technical Stock Forecast Reports - Newser
Is Pasithea Therapeutics Corp. stock a good pick for beginners2025 Technical Patterns & Fast Exit and Entry Strategy Plans - خودرو بانک
Exit strategy if you’re trapped in Pasithea Therapeutics Corp.New Guidance & AI Powered Market Trend Analysis - Newser
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pasithea Therapeutics Corp-Aktie (KTTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):